期刊文献+

小儿恶性肿瘤治愈后远期复发 被引量:3

Late Relapse of Cured Malignant Tumor in Childhood
暂未订购
导出
摘要 目的:报告并讨论小儿肿瘤愈后远期复发。方法:选择小儿时期肿瘤治愈5年以后复发病例,对初发和复发肿瘤的发病年龄、肿瘤种类、复发间隔、治疗等资料进行分析。结果:共收入资料完整者7例,初治最小年龄2岁、最大7岁。复发时最小年龄11岁、最大26岁。肿瘤初发与复发间隔最短7年、最长20年。复发肿瘤包括神经母细胞瘤、恶性神经鞘瘤、肾母细胞瘤、肝母细胞瘤、胰腺囊实性瘤。7例中再次手术后死亡2例,治疗中存活4例,已经随诊1.5年至5年,另有1例确认复发后失访。结论:1)治愈后远期复发的几率不高。2)虽然间隔时间长,但复发肿瘤的基本特点与原发瘤基本一致。3)复发年龄主要在18岁以下。4)局部复发为主,可合并转移。5)远期复发后再治疗仍有治愈机会。 Objective: To report and discuss late relapse of cured malignant tumors in childhood. Methods: The enrolled patients relapsed 5 years after completion of treatment for the primary tumor. Data including age of onset, pathologic type, event-free interval and treatment were analyzed. Results: Seven cases were presented in this study. The age of onset for the initial disease ranged from 2 to 7 years old, while that of relapsed cases ranged from 11 to 26. The event-free interval ranged from 7 to 20 years. The cases included multiple types of malignancies consisting of neuroblastoma, malignant schwannoma, Wilms tumor, hepatoblastoma, and pancreatic cyst (solid tumors). Of the 7 patients, 2 died after the second surgery, 4 survived for 1.5 to 5 years after the second surgery while undergoing treatment or postoperative follow-up. The other patient was lost to follow-up after confirmation of the recurrence. Conclusion: Late relapse of cured malignant tumor in childhood is uncommon. Histopathology of the recurrence remains consistent with the primary tumor, although the event-free interval is quite long. The age of most patients with relapse is usually below 18. Local recurrence occurs in most of the cases, with or without metastasis. Even with recurrent disease, there remains an opportunity to cure the patient after treatment of the relapse.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第13期761-763,共3页 Chinese Journal of Clinical Oncology
关键词 儿童 恶性肿瘤 远期效果 肿瘤复发 Children Neoplasms Long-term survival Late relapse
  • 相关文献

参考文献10

  • 1Ressler IB,Cash J,McNeill D,et al.Continued parental attendance at a clinic for adult survivors of childhood cancer[J].J Pediatr Hematol Oncol,2003,25(11):868-873
  • 2李玉明,詹文华,韩方海,何裕隆,彭俊生,蔡世荣,马晋平,赵刚.胃癌复发的类型、时间和危险因素分析[J].中华外科杂志,2006,44(3):174-176. 被引量:30
  • 3许远,陈力,李国刚,任征.106例进展期胃癌术后复发的诊治经验[J].中国肿瘤临床,2006,33(8):439-441. 被引量:4
  • 4罗祥基,陈汉,吴孟超,姜小清,曲增强,胡雷.原发性肝癌术后肝内复发与肝外转移再手术切除疗效分析[J].中国肿瘤,2005,14(3):158-160. 被引量:17
  • 5Mertens AC,Yasui Y,Neglia JP,et al.Late mortality experience in five-year survivors of childhood and adolescent cancer:the Childhood Cancer Survivor Study[J].J Clin Oncol,2001,19(13):3163-3172
  • 6Strauss SJ,McTiernan A,Whelan JS.Late relapse of osteosarcoma:implications for follow-up and screening[J].Pediatr Blood Cancer,2004,43(6):692-697
  • 7Dama E,Pastore G,Mosso ML,et al.Late deaths among fiveyear survivors of childhood cancer.A population-based study in Piedmont Region,Italy[J].Haematologica,2006,91 (8):1084-1091
  • 8Park ES,Kang HJ,Shin HY,et al.Improved survival in patients with recurrent Wilms tumor:the experience of the Seoul National University Children's Hospital[J].J Korean Med Sci,2006,21 (3):436-440
  • 9Ferrari S,Briccoli A,Mercuri M,et al.Postrelapse survival in osteosarcoma of the extremities:prognostic factors for long-term survival[J].J Clin Oncol,2003,21(4):710-715
  • 10Chi SN,Conklin LS,Qin J,et al.The patterns of relapse in osteosarcoma:the Memorial Sloan-Kettering experience[J].Pediatr Blood Cancer,2004,42(1):46-51

二级参考文献25

  • 1陈峻青.胃癌根治术后复发形式和治疗方法的选择[J].中国实用外科杂志,1995,15(12):709-710. 被引量:55
  • 2Otsuji E,Yamaguchi T,Sawai K,et al.Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma.Cancer,1998,82:1233-1241.
  • 3Macdonald JS.Treatment of localized gastric cancer.Semin Oncol,2004,31:566-573.
  • 4Otsuji E,Kobayashi S,Okamoto K,et al.Is timing of death from tumor recurrence predictable after curative resection for gastric cancer? World J Surg,2001,25:1373-1376.
  • 5Sakar B,Karagol H,Gumus M,et al.Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.Am J Clin Oncol,2004,27:205-209.
  • 6Sugita Y,Fujiwara Y,Taniguchi H,et al.Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer.Int J Oncol,2003,23:1419-1423.
  • 7Otsuji E,Kuriu Y,Ichikawa D,et al.Tumor recurrence and its timing following curative resection of early gastric carcinoma.Anticancer Res,2003,23:3499-3503.
  • 8Takahashi Y,Takeuchi T,Sakamoto J,et al.The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients:a prospective clinical study.Gastric Cancer,2003,6:142-145.
  • 9Glehen O,Mohamed F,Gilly FN.Peritoneal carcinomatosis from digestive tract cancer:new management by cytoreductive surgery and intraperitoneal chemohyperthermia.Lancet Oncol,2004,5:219-228.
  • 10Scaife CL,Calvo FA,Noyes RD.Intraoperative radiotherapy in the multimodality approach to gastric cancer.Surg Oncol Clin N Am,2003,12:955-964.

共引文献48

同被引文献15

  • 1唐锁勤,黄东生,王建文,张晓飞,刘立真,于芳,杨光.强烈化疗和自体外周血造血干细胞移植及维甲酸治疗晚期神经母细胞瘤[J].中华儿科杂志,2004,42(7):486-489. 被引量:5
  • 2唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27
  • 3Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment [ J]. Prog Clin Bid Res, 1994, 385 : 363-369.
  • 4Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[ J]. J Natl Cancer Inst, 2000, 92(3) : 205-216.
  • 5Matthay KK, Atkinson JB, Strata DO, Selch M, Reynolds CP, Seeger RC. Patterns of relapse after autologous purged bone mar- row transplantation for neuroblastoma: a Children's Cancer Group pilot study[J]. J Clin Oncol, 1993, 11 ( 11 ) : 2226-2233.
  • 6Garaventa A, Parodi S, De Bernardi B,Dau D, Manzitti C, Conte M, et al. Outcome of children with neuroblastoma after progres- sion or relapse. A retrospective study of the italian neuroblastoma registry[J]. Eur J Cancer, 2009, 45( 16): 2835-2842.
  • 7Lau L, Tai D, Weitzman S, Grant R, Baruchel S, Malkin D. Factors influencing survival in children with recurrent neuroblasto- ma[J]. J Pediatr Hematol Oncol, 2004, 26(4) : 227-232.
  • 8Miles SA, Sandier AD. CpG oligonucleotides for immunotherapeu- tic treatment of neuroblastoma[ J]. Adv Drug Deliv Rev, 2009, 61 (3) : 275-282.
  • 9Park JR, Digiusto DL, Slovak M, Wright C, Naranjo A, Wagner J, et al. Adoptive transfer of chimeric antigen receptor re-directed eytolytic T lymphocyte clones in patients with neuroblastoma[J]. Mol Ther, 2007, 15(4) : 825-833.
  • 10Shusterman S, Maris JM. Prospects for therapeutic inhibition of neurobtastoma angiogenesis [ J ]. Cancer Lett, 2005, 228 ( 1-2 ) : 171-179.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部